Franklin is recognised for its strong merger control capabilities and is increasingly active in FDI and FSR clearances. Lionel Lesur, a key adviser to companies in the life sciences, retail, financial services and luxury sectors, leads the practice, which also covers FCA investigations, competition compliance and distribution law.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Franklin has a very integrated approach between the corporate and competition teams, which allows for a great capacity to react to customer needs and a great capacity for innovation.’
  • ‘Lionel Lesur is available and attentive, always ready to find innovative solutions.’
  • ‘Excellent.’

Key clients

  • DocMorris A.G.
  • Doctipharma SAS
  • Danone
  • IBL Ltd.
  • Promofarma
  • STOA Infra & Energy
  • Ipsos
  • LuminUltra Technologies Ltd.
  • Verdoso Investment SAS
  • Mech-I-Tronic

Work highlights

Assisting DocMorris’ French subsidiary, Doctipharma, in ongoing proceedings before the Paris Court of Appeal, including the successful referral of several preliminary questions to the European Court of Justice.
Assisted Verdoso SAS in the granting, in June 2024, of the unconditional authorization from the French Competition Authority of the acquisition of sole control of Groupe Rétif SAS (as well as on the disposal of this sole control to competitor Raja).
Assisted Verdoso SAS in the granting, in March 2025, of the unconditional authorisation from the French Competition Authority of the acquisition of sole control of The Kooples Production SAS.
Practice head

Lionel Lesur